001     275859
005     20250113165814.0
024 7 _ |a 10.1016/j.nsa.2024.104075
|2 doi
037 _ _ |a DZNE-2025-00094
100 1 _ |a Garrett, Lillian
|b 0
245 _ _ |a Co-expression of prepulse inhibition and Schizophrenia genes in the mouse and human brain
260 _ _ |a Amsterdam
|c 2024
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736773887_1045
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Schizophrenia is a complex psychiatric disorder with genetic and phenotypic heterogeneity. Accumulating rare and genome-wide association study (GWAS) common risk variant information has yet to yield robust mechanistic insight. Leveraging large-scale gene deletion mouse phenomic data thus has potential to functionally interrogate and prioritize human disease genes. To this end, we applied a cross-species network-based approach to parse an extensive mouse gene set (188 genes) associated with disrupted prepulse inhibition (PPI), a Schizophrenia endophenotype. Integrating PPI genes with high-resolution mouse and human brain transcriptomic data, we identified functional and disease coherent co-expression modules through hierarchical clustering and weighted gene co-expression network analysis (WGCNA). In two modules, Schizophrenia risk and mouse PPI genes converged based on telencephalic patterning. The associated neuronal genes were highly expressed in cingulate cortex and hippocampus; implicated in synaptic function and neurotransmission and overlapped with the greatest proportion of rare variants. Concordant neuroanatomical patterning revealed novel core Schizophrenia-relevant genes consistent with the Omnigenic hypothesis of complex traits. Among other genes discussed, the developmental and post-synaptic scaffold TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2) emerged from both networks as a novel core genetic driver of Schizophrenia altering PPI. Aspects of psychiatric disease comorbidity and phenotypic heterogeneity are also explored. Overall, this study provides a framework and galvanizes the value of mouse preclinical genetics and PPI to prioritize both existing and novel human Schizophrenia candidate genes as druggable targets.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Trumbach, Dietrich
|0 P:(DE-2719)9000367
|b 1
700 1 _ |a Lee, Donghyung
|b 2
700 1 _ |a Mandillo, Silvia
|0 0000-0002-4869-0974
|b 3
700 1 _ |a Samaco, Rodney
|0 0000-0001-5636-5314
|b 4
700 1 _ |a Flenniken, Ann M.
|b 5
700 1 _ |a Stewart, Michelle
|b 6
700 1 _ |a Aguilar-Pimental, Juan A.
|b 7
700 1 _ |a Amarie, Oana V.
|b 8
700 1 _ |a Becker, Lore
|b 9
700 1 _ |a Calzada-Wack, Julia
|b 10
700 1 _ |a Da Silva-Buttkus, Patricia
|b 11
700 1 _ |a Dragano, Nathalia
|b 12
700 1 _ |a Kraiger, Markus
|b 13
700 1 _ |a Lengger, Christoph
|b 14
700 1 _ |a Leuchtenberger, Stefanie
|b 15
700 1 _ |a Marschall, Susan
|b 16
700 1 _ |a Oestereicher, Manuela A.
|b 17
700 1 _ |a Rathkolb, Birgit
|b 18
700 1 _ |a Sanz-Moreno, Adrián
|b 19
700 1 _ |a Seisenberger, Claudia
|b 20
700 1 _ |a Spielmann, Nadine
|b 21
700 1 _ |a Stoeger, Claudia
|b 22
700 1 _ |a Kumar, Vivek
|b 23
700 1 _ |a Keskivali, Piia
|b 24
700 1 _ |a King, Ruairidh
|b 25
700 1 _ |a Haselimashhadi, Hamed
|b 26
700 1 _ |a Bezginov, Alexandr
|b 27
700 1 _ |a Norris, Clare
|b 28
700 1 _ |a Taylor, Sarah
|b 29
700 1 _ |a Pimm, Dale
|b 30
700 1 _ |a Kelsey, Lois
|b 31
700 1 _ |a Berberovic, Zorana
|b 32
700 1 _ |a Qu, Dawei
|b 33
700 1 _ |a D'Souza, Abigail
|b 34
700 1 _ |a Bradaschia, Vivian
|b 35
700 1 _ |a Eskandarian, Mohammed
|b 36
700 1 _ |a Shang, Xueyuan
|b 37
700 1 _ |a Duffin, Kyle
|b 38
700 1 _ |a Roberton, Kyle
|b 39
700 1 _ |a Xu, Catherine
|b 40
700 1 _ |a Baguinat, Gloria
|b 41
700 1 _ |a Laurin, Valerie
|b 42
700 1 _ |a Lan, Qing
|b 43
700 1 _ |a Sleep, Gillian
|b 44
700 1 _ |a Lintott, Lauri
|b 45
700 1 _ |a Gertsenstein, Marina
|b 46
700 1 _ |a Tondat, Sandra
|b 47
700 1 _ |a Cruz, Maribelle
|b 48
700 1 _ |a Miller, David
|b 49
700 1 _ |a Bezginov, Alexandr
|b 50
700 1 _ |a Sorg, Tania
|b 51
700 1 _ |a Riet, Fabrice
|b 52
700 1 _ |a Tolentino, Heather
|b 53
700 1 _ |a Tolentino, Todd
|b 54
700 1 _ |a Schuchbauer, Mike
|b 55
700 1 _ |a Hockenbury, Nichole
|b 56
700 1 _ |a Beeman, Karrie
|b 57
700 1 _ |a Pedroia, Sheryl
|b 58
700 1 _ |a Salazar, Jason
|b 59
700 1 _ |a Heffner, Mollie
|b 60
700 1 _ |a Hsu, Joanne
|b 61
700 1 _ |a Fletcher, Colin
|b 62
700 1 _ |a Vanzanten, Maya
|b 63
700 1 _ |a Golini, Elisabetta
|b 64
700 1 _ |a Seavitt, John R.
|b 65
700 1 _ |a Lanza, Denise G.
|b 66
700 1 _ |a Lorenzo, Isabel
|b 67
700 1 _ |a Gaspero, Angelina
|b 68
700 1 _ |a Rios, Amanda
|b 69
700 1 _ |a White, Jacqueline K.
|b 70
700 1 _ |a McKerlie, Colin
|b 71
700 1 _ |a Nutter, Lauryl M. J.
|0 0000-0001-9619-146X
|b 72
700 1 _ |a Vukobradovic, Igor
|b 73
700 1 _ |a Veeraragavan, Surabi
|b 74
700 1 _ |a Yuva, Lisa
|b 75
700 1 _ |a Heaney, Jason D.
|b 76
700 1 _ |a Dickinson, Mary E.
|b 77
700 1 _ |a Meziane, Hamid
|0 0000-0002-4704-7055
|b 78
700 1 _ |a Hérault, Yann
|0 0000-0001-7049-6900
|b 79
700 1 _ |a Wells, Sara
|0 0000-0002-0572-0600
|b 80
700 1 _ |a Lloyd, K. C. Kent
|0 0000-0002-5318-4144
|b 81
700 1 _ |a Bower, Lynette
|b 82
700 1 _ |a Lanoue, Louise
|b 83
700 1 _ |a Clary, Dave
|0 0000-0002-3315-7333
|b 84
700 1 _ |a Zimprich, Annemarie
|0 0000-0003-2078-6779
|b 85
700 1 _ |a Gailus-Durner, Valerie
|b 86
700 1 _ |a Fuchs, Helmut
|b 87
700 1 _ |a Brown, Steve D. M.
|b 88
700 1 _ |a Chesler, Elissa J.
|0 0000-0002-5642-5062
|b 89
700 1 _ |a Wurst, Wolfgang
|0 P:(DE-2719)2000028
|b 90
|u dzne
700 1 _ |a Hrabě de Angelis, Martin
|b 91
700 1 _ |a Hölter, Sabine M.
|b 92
773 _ _ |a 10.1016/j.nsa.2024.104075
|g Vol. 3, p. 104075 -
|0 PERI:(DE-600)3154568-3
|p 104075
|t Neuroscience Applied
|v 3
|y 2024
|x 2772-4085
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/275859/files/DZNE-2025-00094.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/275859/files/DZNE-2025-00094.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:275859
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 90
|6 P:(DE-2719)2000028
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
920 1 _ |0 I:(DE-2719)1140001
|k AG Wurst
|l Genome Engineering
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1140001


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21